Gene Therapy for Neurodegenerative Diseases: Slowing Down the Ticking Clock
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gene Therapy for Neurodegenerative Diseases: Slowing Down the Ticking Clock
Authors
Keywords
-
Journal
Frontiers in Neuroscience
Volume 14, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-09-18
DOI
10.3389/fnins.2020.580179
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Transduction patterns in the CNS following various routes of AAV-5-mediated gene delivery
- (2020) K. L. Pietersz et al. GENE THERAPY
- Artificial MicroRNAs Targeting C9orf72 Can Reduce Accumulation of Intra-nuclear Transcripts in ALS and FTD Patients
- (2019) Raygene Martier et al. Molecular Therapy-Nucleic Acids
- Heterochromatin anomalies and double-stranded RNA accumulation underlie C9orf72 poly(PR) toxicity
- (2019) Yong-Jie Zhang et al. SCIENCE
- Therapeutic AAV Gene Transfer to the Nervous System: A Clinical Reality
- (2019) Eloise Hudry et al. NEURON
- C9orf72-dependent lysosomal functions regulate epigenetic control of autophagy and lipid metabolism
- (2019) Yang Liu et al. Autophagy
- Targeting Huntingtin Expression in Patients with Huntington’s Disease
- (2019) Sarah J. Tabrizi et al. NEW ENGLAND JOURNAL OF MEDICINE
- In-depth characterization of a Mifepristone regulated expression system for AAV5-mediated gene therapy in the liver
- (2019) Jolanda M. Liefhebber et al. Molecular Therapy-Methods & Clinical Development
- Targeting RNA-Mediated Toxicity in C9orf72 ALS and/or FTD by RNAi-Based Gene Therapy
- (2019) Raygene Martier et al. Molecular Therapy-Nucleic Acids
- AAV5-miHTT Lowers Huntingtin mRNA and Protein without Off-Target Effects in Patient-Derived Neuronal Cultures and Astrocytes
- (2019) Sonay Keskin et al. Molecular Therapy-Methods & Clinical Development
- Development of an AAV-Based MicroRNA Gene Therapy to Treat Machado-Joseph Disease
- (2019) Raygene Martier et al. Molecular Therapy-Methods & Clinical Development
- MicroRNAs as Clinical Biomarkers and Therapeutic Tools in Perioperative Medicine
- (2018) Simone Kreth et al. ANESTHESIA AND ANALGESIA
- Evaluation of Intrathecal Routes of Administration for Adeno-Associated Viral Vectors in Large Animals
- (2018) Christian Hinderer et al. HUMAN GENE THERAPY
- Exon-skipping advances for Duchenne muscular dystrophy
- (2018) Lucía Echevarría et al. HUMAN MOLECULAR GENETICS
- Machado-Joseph disease / Spinocerebellar ataxia type 3:lessons from disease pathogenesis and clues into therapy
- (2018) Carlos Matos et al. JOURNAL OF NEUROCHEMISTRY
- Amyotrophic Lateral Sclerosis: An Update for 2018
- (2018) Björn Oskarsson et al. MAYO CLINIC PROCEEDINGS
- Update on phase 1/2 clinical trials for MPS I and MPS II using ZFN-mediated in vivo genome editing
- (2018) Paul Harmatz et al. MOLECULAR GENETICS AND METABOLISM
- Dose-Dependent Prevention of Metabolic and Neurologic Disease in Murine MPS II by ZFN-Mediated In Vivo Genome Editing
- (2018) Kanut Laoharawee et al. MOLECULAR THERAPY
- Translation of MicroRNA-Based Huntingtin-Lowering Therapies from Preclinical Studies to the Clinic
- (2018) Jana Miniarikova et al. MOLECULAR THERAPY
- AAV5-miHTT Gene Therapy Demonstrates Broad Distribution and Strong Human Mutant Huntingtin Lowering in a Huntington’s Disease Minipig Model
- (2018) Melvin M. Evers et al. MOLECULAR THERAPY
- First in vivo human genome editing trial
- (2018) NATURE BIOTECHNOLOGY
- Haploinsufficiency leads to neurodegeneration in C9ORF72 ALS/FTD human induced motor neurons
- (2018) Yingxiao Shi et al. NATURE MEDICINE
- CRISPR/Cas9-Targeted Deletion of Polyglutamine in Spinocerebellar Ataxia Type 3-Derived Induced Pluripotent Stem Cells
- (2018) Shuming Ouyang et al. STEM CELLS AND DEVELOPMENT
- Adeno-Associated Viral Vector (Serotype 2)–Nerve Growth Factor for Patients With Alzheimer Disease
- (2018) Michael S. Rafii et al. JAMA Neurology
- AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease
- (2018) Jonathan B. Rosenberg et al. Human Gene Therapy Clinical Development
- Therapeutic efficacy of regulable GDNF expression for Huntington's and Parkinson's disease by a high-induction, background-free “GeneSwitch” vector
- (2018) Shi Cheng et al. EXPERIMENTAL NEUROLOGY
- A brief account of viral vectors and their promise for gene therapy
- (2017) M Finer et al. GENE THERAPY
- MR-guided parenchymal delivery of adeno-associated viral vector serotype 5 in non-human primate brain
- (2017) L Samaranch et al. GENE THERAPY
- AAV5-miHTT gene therapy demonstrates suppression of mutant huntingtin aggregation and neuronal dysfunction in a rat model of Huntington’s disease
- (2017) J Miniarikova et al. GENE THERAPY
- Clinical Gene Therapy for Neurodegenerative Diseases: Past, Present, and Future
- (2017) Françoise Piguet et al. HUMAN GENE THERAPY
- TDP-43 mutations causing amyotrophic lateral sclerosis are associated with altered expression of RNA-binding protein hnRNP K and affect the Nrf2 antioxidant pathway
- (2017) Diane Moujalled et al. HUMAN MOLECULAR GENETICS
- CRISPR/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington’s disease
- (2017) Su Yang et al. JOURNAL OF CLINICAL INVESTIGATION
- Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery
- (2017) Chaitanya R. Joshi et al. Journal of Neuroimmune Pharmacology
- Polyglutamine tracts regulate beclin 1-dependent autophagy
- (2017) Avraham Ashkenazi et al. NATURE
- Emptying the stores: lysosomal diseases and therapeutic strategies
- (2017) Frances M. Platt NATURE REVIEWS DRUG DISCOVERY
- Antisense oligonucleotides: the next frontier for treatment of neurological disorders
- (2017) Carlo Rinaldi et al. Nature Reviews Neurology
- Polyglutamine spinocerebellar ataxias — from genes to potential treatments
- (2017) Henry L. Paulson et al. NATURE REVIEWS NEUROSCIENCE
- AVXS-101 phase 1 gene therapy clinical trial in SMA Type 1: end-of-Study event free survival and achievement of developmental milestones
- (2017) J. Mendell et al. NEUROMUSCULAR DISORDERS
- Dicer-independent processing of small RNA duplexes: mechanistic insights and applications
- (2017) Elena Herrera-Carrillo et al. NUCLEIC ACIDS RESEARCH
- Rescue of Pompe disease in mice by AAV-mediated liver delivery of secretable acid α-glucosidase
- (2017) Francesco Puzzo et al. Science Translational Medicine
- Genome-scale measurement of off-target activity using Cas9 toxicity in high-throughput screens
- (2017) David W. Morgens et al. Nature Communications
- Unraveling the Role of RNA Mediated Toxicity of C9orf72 Repeats in C9-FTD/ALS
- (2017) Vijay Kumar et al. Frontiers in Neuroscience
- Antisense Oligonucleotide-Mediated Removal of the Polyglutamine Repeat in Spinocerebellar Ataxia Type 3 Mice
- (2017) Lodewijk J.A. Toonen et al. Molecular Therapy-Nucleic Acids
- Therapeutic miRNA and siRNA: Moving from Bench to Clinic as Next Generation Medicine
- (2017) Chiranjib Chakraborty et al. Molecular Therapy-Nucleic Acids
- Low-Dose Liver-Targeted Gene Therapy for Pompe Disease Enhances Therapeutic Efficacy of ERT via Immune Tolerance Induction
- (2017) Sang-oh Han et al. Molecular Therapy-Methods & Clinical Development
- Protein misfolding in neurodegenerative diseases: implications and strategies
- (2017) Patrick Sweeney et al. Translational Neurodegeneration
- The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington’s disease patients
- (2017) Andreas Neueder et al. Scientific Reports
- There has been an awakening: Emerging mechanisms of C9orf72 mutations in FTD/ALS
- (2016) Aaron D. Gitler et al. BRAIN RESEARCH
- Adeno-Associated Virus-Based Gene Therapy for CNS Diseases
- (2016) Michaël Hocquemiller et al. HUMAN GENE THERAPY
- Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors
- (2016) Muhammad S. Beg et al. INVESTIGATIONAL NEW DRUGS
- Gene therapy for the CNS using AAVs: The impact of systemic delivery by AAV9
- (2016) Joana Saraiva et al. JOURNAL OF CONTROLLED RELEASE
- Self-Complementary AAV9 Gene Delivery Partially Corrects Pathology Associated with Juvenile Neuronal Ceroid Lipofuscinosis (CLN3)
- (2016) M. E. Bosch et al. JOURNAL OF NEUROSCIENCE
- 258. Phase I/IIa Study of TT-034, a DNA-Directed RNA Interference (ddRNAi) Agent Delivered as a Single Administration for the Treatment of Subjects with Chronic Hepatitis C Virus (HCV)
- (2016) Keyur Patel et al. MOLECULAR THERAPY
- 567. CRISPR-Cas9 Mediated Gene Editing in a Monogenic Form of Alzheimer's Disease
- (2016) Bence Gyorgy et al. MOLECULAR THERAPY
- Cre-dependent selection yields AAV variants for widespread gene transfer to the adult brain
- (2016) Benjamin E Deverman et al. NATURE BIOTECHNOLOGY
- The Prevalence of Huntington's Disease
- (2016) Michael D. Rawlins et al. NEUROEPIDEMIOLOGY
- Comparative analysis of C9orf72 and sporadic disease in an ALS clinic population
- (2016) Mfon E. Umoh et al. NEUROLOGY
- C9orf72 BAC Mouse Model with Motor Deficits and Neurodegenerative Features of ALS/FTD
- (2016) Yuanjing Liu et al. NEURON
- Gain of Toxicity from ALS/FTD-Linked Repeat Expansions in C9ORF72 Is Alleviated by Antisense Oligonucleotides Targeting GGGGCC-Containing RNAs
- (2016) Jie Jiang et al. NEURON
- RNA cleavage products generated by antisense oligonucleotides and siRNAs are processed by the RNA surveillance machinery
- (2016) Walt F. Lima et al. NUCLEIC ACIDS RESEARCH
- Splice-switching antisense oligonucleotides as therapeutic drugs
- (2016) Mallory A. Havens et al. NUCLEIC ACIDS RESEARCH
- The delivery of therapeutic oligonucleotides
- (2016) Rudolph L. Juliano NUCLEIC ACIDS RESEARCH
- Design, Characterization, and Lead Selection of Therapeutic miRNAs Targeting Huntingtin for Development of Gene Therapy for Huntington's Disease
- (2016) Jana Miniarikova et al. Molecular Therapy-Nucleic Acids
- 395. OXB-102: An Enhanced Gene Therapy for Parkinson's Disease
- (2016) MOLECULAR THERAPY
- Antisense oligonucleotides in therapy for neurodegenerative disorders
- (2015) Melvin M. Evers et al. ADVANCED DRUG DELIVERY REVIEWS
- Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial
- (2015) C. Warren Olanow et al. ANNALS OF NEUROLOGY
- C9orf72 ablation in mice does not cause motor neuron degeneration or motor deficits
- (2015) Max Koppers et al. ANNALS OF NEUROLOGY
- A large animal model of spinal muscular atrophy and correction of phenotype
- (2015) Sandra I. Duque et al. ANNALS OF NEUROLOGY
- Genetics of the neuronal ceroid lipofuscinoses (Batten disease)
- (2015) Sara E. Mole et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Improving Single Injection CSF Delivery of AAV9-mediated Gene Therapy for SMA: A Dose–response Study in Mice and Nonhuman Primates
- (2015) Kathrin Meyer et al. MOLECULAR THERAPY
- Genome Editing Technologies: Defining a Path to Clinic
- (2015) Jacqueline Corrigan-Curay et al. MOLECULAR THERAPY
- The C9orf72 repeat expansion disrupts nucleocytoplasmic transport
- (2015) Ke Zhang et al. NATURE
- GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport
- (2015) Brian D. Freibaum et al. NATURE
- Inducible in vivo genome editing with CRISPR-Cas9
- (2015) Lukas E Dow et al. NATURE BIOTECHNOLOGY
- Modifiers of C9orf72 dipeptide repeat toxicity connect nucleocytoplasmic transport defects to FTD/ALS
- (2015) Ana Jovičić et al. NATURE NEUROSCIENCE
- A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3/MJD
- (2015) Pawel M. Switonski et al. NEUROBIOLOGY OF DISEASE
- Human C9ORF72 Hexanucleotide Expansion Reproduces RNA Foci and Dipeptide Repeat Proteins but Not Neurodegeneration in BAC Transgenic Mice
- (2015) Owen M. Peters et al. NEURON
- C9orf72 BAC Transgenic Mice Display Typical Pathologic Features of ALS/FTD
- (2015) Jacqueline G. O’Rourke et al. NEURON
- C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits
- (2015) J. Chew et al. SCIENCE
- Inactivation of PNKP by Mutant ATXN3 Triggers Apoptosis by Activating the DNA Damage-Response Pathway in SCA3
- (2015) Rui Gao et al. PLoS Genetics
- The Role of the Mammalian DNA End-processing Enzyme Polynucleotide Kinase 3’-Phosphatase in Spinocerebellar Ataxia Type 3 Pathogenesis
- (2015) Arpita Chatterjee et al. PLoS Genetics
- Off-target Effects in CRISPR/Cas9-mediated Genome Engineering
- (2015) Xiao-Hui Zhang et al. Molecular Therapy-Nucleic Acids
- Evaluation of Readministration of a Recombinant Adeno-Associated Virus Vector Expressing Acid Alpha-Glucosidase in Pompe Disease: Preclinical to Clinical Planning
- (2015) Manuela Corti et al. Human Gene Therapy Clinical Development
- Risk factors for amyotrophic lateral sclerosis
- (2015) Fang Fang et al. Clinical Epidemiology
- Huntington disease
- (2015) Gillian P. Bates et al. Nature Reviews Disease Primers
- Aggregation-prone c9FTD/ALS poly(GA) RAN-translated proteins cause neurotoxicity by inducing ER stress
- (2014) Yong-Jie Zhang et al. ACTA NEUROPATHOLOGICA
- Pathogenesis/genetics of frontotemporal dementia and how it relates to ALS
- (2014) Janis Bennion Callister et al. EXPERIMENTAL NEUROLOGY
- Intracerebral Administration of Adeno-Associated Viral Vector Serotype rh.10 Carrying Human SGSH and SUMF1 cDNAs in Children with Mucopolysaccharidosis Type IIIA Disease: Results of a Phase I/II Trial
- (2014) Marc Tardieu et al. HUMAN GENE THERAPY
- Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9
- (2014) Rajat M. Gupta et al. JOURNAL OF CLINICAL INVESTIGATION
- Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial
- (2014) Stéphane Palfi et al. LANCET
- Adeno-Associated Virus Vectors and Neurological Gene Therapy
- (2014) David S. Ojala et al. NEUROSCIENTIST
- Immunosuppressive Treatment for Retinal Degeneration in Juvenile Neuronal Ceroid Lipofuscinosis (Juvenile Batten Disease)
- (2014) Arlene V. Drack et al. OPHTHALMIC GENETICS
- C9orf72 repeat expansions cause neurodegeneration in Drosophila through arginine-rich proteins
- (2014) S. Mizielinska et al. SCIENCE
- Modelling C9ORF72 hexanucleotide repeat expansion in amyotrophic lateral sclerosis and frontotemporal dementia
- (2013) Alan Stepto et al. ACTA NEUROPATHOLOGICA
- Protein aggregation in amyotrophic lateral sclerosis
- (2013) Anna M. Blokhuis et al. ACTA NEUROPATHOLOGICA
- NCL diseases — clinical perspectives
- (2013) Angela Schulz et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Phase I/II Trial of Adeno-Associated Virus–Mediated Alpha-Glucosidase Gene Therapy to the Diaphragm for Chronic Respiratory Failure in Pompe Disease: Initial Safety and Ventilatory Outcomes
- (2013) Barbara K. Smith et al. HUMAN GENE THERAPY
- An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study
- (2013) Timothy M Miller et al. LANCET NEUROLOGY
- Ataxin-3 Protein and RNA Toxicity in Spinocerebellar Ataxia Type 3: Current Insights and Emerging Therapeutic Strategies
- (2013) Melvin M. Evers et al. MOLECULAR NEUROBIOLOGY
- Toward RNAi Therapy for the Polyglutamine Disease Machado–Joseph Disease
- (2013) Maria do Carmo Costa et al. MOLECULAR THERAPY
- Multisource ascertainment of Huntington disease in Canada: Prevalence and population at risk
- (2013) Emily R. Fisher et al. MOVEMENT DISORDERS
- Lack of C9ORF72 coding mutations supports a gain of function for repeat expansions in amyotrophic lateral sclerosis
- (2013) Matthew B. Harms et al. NEUROBIOLOGY OF AGING
- Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients
- (2013) R. T. Bartus et al. NEUROLOGY
- RNA Toxicity from the ALS/FTD C9ORF72 Expansion Is Mitigated by Antisense Intervention
- (2013) Christopher J. Donnelly et al. NEURON
- Miravirsen (SPC3649) can inhibit the biogenesis of miR-122
- (2013) Luca F. R. Gebert et al. NUCLEIC ACIDS RESEARCH
- Silencing Mutant Ataxin-3 Rescues Motor Deficits and Neuropathology in Machado-Joseph Disease Transgenic Mice
- (2013) Clévio Nóbrega et al. PLoS One
- Analysis of Transduction Efficiency, Tropism and Axonal Transport of AAV Serotypes 1, 2, 5, 6, 8 and 9 in the Mouse Brain
- (2013) Dominik F. Aschauer et al. PLoS One
- RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia
- (2013) T. Zu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Expanded GGGGCC repeat RNA associated with amyotrophic lateral sclerosis and frontotemporal dementia causes neurodegeneration
- (2013) Z. Xu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration
- (2013) C. Lagier-Tourenne et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting RNA Foci in iPSC-Derived Motor Neurons from ALS Patients with a C9ORF72 Repeat Expansion
- (2013) D. Sareen et al. Science Translational Medicine
- Developmental neuroplasticity and the origin of neurodegenerative diseases
- (2013) Andrea T. U. Schaefers et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- Mechanisms of RNA-induced toxicity in CAG repeat disorders
- (2013) R Nalavade et al. Cell Death & Disease
- Overexpression of Mutant Ataxin-3 in Mouse Cerebellum Induces Ataxia and Cerebellar Neuropathology
- (2012) Clévio Nóbrega et al. CEREBELLUM
- Long-Term Evaluation of a Phase 1 Study of AADC Gene Therapy for Parkinson's Disease
- (2012) Gabriele Mittermeyer et al. HUMAN GENE THERAPY
- Ataxin-3 Regulates Aggresome Formation of Copper-Zinc Superoxide Dismutase (SOD1) by Editing K63-linked Polyubiquitin Chains
- (2012) Hongfeng Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- RNA-mediated toxicity in neurodegenerative disease
- (2012) Veronique V. Belzil et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Mouse Models of Spinocerebellar Ataxia Type 3 (Machado-Joseph Disease)
- (2012) Veronica F. Colomer Gould Neurotherapeutics
- Long-Term Follow-Up After Gene Therapy for Canavan Disease
- (2012) P. Leone et al. Science Translational Medicine
- MicroRNA-21 Promotes Fibrosis of the Kidney by Silencing Metabolic Pathways
- (2012) B. N. Chau et al. Science Translational Medicine
- Guided delivery of adeno-associated viral vectors into the primate brain
- (2011) Ernesto A. Salegio et al. ADVANCED DRUG DELIVERY REVIEWS
- FTD and ALS: A Tale of Two Diseases
- (2011) R. Ferrari et al. Current Alzheimer Research
- AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial
- (2011) Peter A LeWitt et al. LANCET NEUROLOGY
- Alternative miRNA Biogenesis Pathways and the Interpretation of Core miRNA Pathway Mutants
- (2011) Jr-Shiuan Yang et al. MOLECULAR CELL
- Systemic Gene Delivery in Large Species for Targeting Spinal Cord, Brain, and Peripheral Tissues for Pediatric Disorders
- (2011) Adam K Bevan et al. MOLECULAR THERAPY
- Correction of Neurological Disease of Mucopolysaccharidosis IIIB in Adult Mice by rAAV9 Trans-Blood–Brain Barrier Gene Delivery
- (2011) Haiyan Fu et al. MOLECULAR THERAPY
- Phase 1 Gene Therapy for Duchenne Muscular Dystrophy Using a Translational Optimized AAV Vector
- (2011) Dawn E Bowles et al. MOLECULAR THERAPY
- Novel Platform for MRI-Guided Convection-Enhanced Delivery of Therapeutics: Preclinical Validation in Nonhuman Primate Brain
- (2011) R. Mark Richardson et al. STEREOTACTIC AND FUNCTIONAL NEUROSURGERY
- Muscleblind participates in RNA toxicity of expanded CAG and CUG repeats in Caenorhabditis elegans
- (2010) Li-Chun Wang et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Intrathecal Injection of Helper-Dependent Adenoviral Vectors Results in Long-Term Transgene Expression in Neuroependymal Cells and Neurons
- (2010) Scott Dindot et al. HUMAN GENE THERAPY
- Early heart failure in the SMNΔ7 model of spinal muscular atrophy and correction by postnatal scAAV9-SMN delivery
- (2010) Adam K. Bevan et al. HUMAN MOLECULAR GENETICS
- TDP-43: A DNA and RNA binding protein with roles in neurodegenerative diseases
- (2010) Sadaf T. Warraich et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial
- (2010) William J Marks et al. LANCET NEUROLOGY
- Huntington's disease: from molecular pathogenesis to clinical treatment
- (2010) Christopher A Ross et al. LANCET NEUROLOGY
- Safe, Efficient, and Reproducible Gene Therapy of the Brain in the Dog Models of Sanfilippo and Hurler Syndromes
- (2010) N Matthew Ellinwood et al. MOLECULAR THERAPY
- A dicer-independent miRNA biogenesis pathway that requires Ago catalysis
- (2010) Sihem Cheloufi et al. NATURE
- TAR DNA-binding protein 43 in neurodegenerative disease
- (2010) Alice S. Chen-Plotkin et al. Nature Reviews Neurology
- Motor uncoordination and neuropathology in a transgenic mouse model of Machado–Joseph disease lacking intranuclear inclusions and ataxin-3 cleavage products
- (2010) Anabela Silva-Fernandes et al. NEUROBIOLOGY OF DISEASE
- Amyotrophic lateral sclerosis and frontotemporal lobar degeneration: A spectrum of TDP-43 proteinopathies
- (2010) Felix Geser et al. NEUROPATHOLOGY
- Dystrophin Immunity in Duchenne's Muscular Dystrophy
- (2010) Jerry R. Mendell et al. NEW ENGLAND JOURNAL OF MEDICINE
- A viral assembly factor promotes AAV2 capsid formation in the nucleolus
- (2010) F. Sonntag et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Non-ATG-initiated translation directed by microsatellite expansions
- (2010) T. Zu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Conserved vertebrate mir-451 provides a platform for Dicer-independent, Ago2-mediated microRNA biogenesis
- (2010) J.-S. Yang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A Novel miRNA Processing Pathway Independent of Dicer Requires Argonaute2 Catalytic Activity
- (2010) D. Cifuentes et al. SCIENCE
- RNA-Based Gene Therapy for HIV with Lentiviral Vector-Modified CD34+ Cells in Patients Undergoing Transplantation for AIDS-Related Lymphoma
- (2010) D. L. DiGiusto et al. Science Translational Medicine
- New insights into the pathoanatomy of spinocerebellar ataxia type 3 (Machado–Joseph disease)
- (2009) Udo Rüb et al. CURRENT OPINION IN NEUROLOGY
- Ubiquitination directly enhances activity of the deubiquitinating enzyme ataxin-3
- (2009) Sokol V Todi et al. EMBO JOURNAL
- RNAi-based therapeutics-current status, challenges and prospects
- (2009) Katrin Tiemann et al. EMBO Molecular Medicine
- Preventing Ataxin-3 protein cleavage mitigates degeneration in a Drosophila model of SCA3
- (2009) Joonil Jung et al. HUMAN MOLECULAR GENETICS
- Reversibility of symptoms in a conditional mouse model of spinocerebellar ataxia type 3
- (2009) Jana Boy et al. HUMAN MOLECULAR GENETICS
- Prion-like mechanisms in neurodegenerative diseases
- (2009) Bess Frost et al. NATURE REVIEWS NEUROSCIENCE
- A transgenic mouse model of spinocerebellar ataxia type 3 resembling late disease onset and gender-specific instability of CAG repeats
- (2009) Jana Boy et al. NEUROBIOLOGY OF DISEASE
- Safety and tolerability of putaminal AADC gene therapy for Parkinson disease
- (2009) C. W. Christine et al. NEUROLOGY
- ALS motor phenotype heterogeneity, focality, and spread: Deconstructing motor neuron degeneration
- (2009) J. M. Ravits et al. NEUROLOGY
- Nucleocytoplasmic Shuttling Activity of Ataxin-3
- (2009) Sandra Macedo-Ribeiro et al. PLoS One
- microRNA-122 stimulates translation of hepatitis C virus RNA
- (2008) Jura Inga Henke et al. EMBO JOURNAL
- Treatment of Late Infantile Neuronal Ceroid Lipofuscinosis by CNS Administration of a Serotype 2 Adeno-Associated Virus Expressing CLN2 cDNA
- (2008) Stefan Worgall et al. HUMAN GENE THERAPY
- Liver-Specific MicroRNA miR-122 Enhances the Replication of Hepatitis C Virus in Nonhepatic Cells
- (2008) J. Chang et al. JOURNAL OF VIROLOGY
- Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2–neurturin) to patients with idiopathic Parkinson's disease: an open-label, phase I trial
- (2008) William J Marks et al. LANCET NEUROLOGY
- Do early-life insults contribute to the late-life development of Parkinson and Alzheimer diseases?
- (2008) Diane B. Miller et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Analysis of AAV Serotypes 1–9 Mediated Gene Expression and Tropism in Mice After Systemic Injection
- (2008) Carmela Zincarelli et al. MOLECULAR THERAPY
- Polyglutamine-expanded ataxin-3 causes cerebellar dysfunction of SCA3 transgenic mice by inducing transcriptional dysregulation
- (2008) An-Hsun Chou et al. NEUROBIOLOGY OF DISEASE
- Results from a phase I safety trial of hAADC gene therapy for Parkinson disease
- (2008) J. L. Eberling et al. NEUROLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now